Biotest AG Q1-Q3 2016 Analyst Conference

Biotest AG presented Q1-Q3 2016 financial results showing sales growth to €455.6 million and improved EBIT performance. The presentation highlights expansion of plasma collection centers in the US and Hungary, alongside progress on the "Biotest Next Level" strategic initiative.